Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment. is a research paper published in Apollo (University of Cambridge) (2021). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
European Research Council
Grant: HEALTH-F2-2009-223175
Ministère de l'Économie, de la Science et de l'Innovation - Québec
Grant: PSRSIIRI-701
Horizon 2020 Research and Innovation Programme
Grant: 633784, 634935
NIH HHS
Grant: CA128978, U19 CA148065
GAME-ON
Grant: 1U19 CA148112
CIHR
Grant: GPH-129344
Post-Cancer GWAS
Grant: 1U19 CA148537, 1U19 CA148065
U.S. Department of Defense
Grant: W81XWH-10-1-0341
Cancer Research UK
Grant: C1281/A12014, C5047/A15007, C1287/A10710, C5047/A10692, C5047/A8384, C1287/A10118, C1287/A16563, C8197/A16565, C12292/A11174
FWCI
0.00
Citation Percentile
0.1%
Fields of Study
Keywords
Sustainable Development Goals